Last reviewed · How we verify

NCT03781544: OPIOVASC

Effects of Opioids and NSAIDs on Sympathetic Nervous System and Vascular Function

Recruiting now Phase 4 Last updated 17 May 2024
What this trial tests

Phase 4 trial testing Tramadol in Osteoarthritis of Multiple Joints of Ankle or Foot in 90 participants. Currently enrolling.

Timeline
1 January 2019
Primary endpoint
31 July 2025
31 December 2025

Quick facts

Lead sponsorUniversity of Zurich
PhasePhase 4
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment90
Start date1 January 2019
Primary completion31 July 2025
Estimated completion31 December 2025
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University of Zurich

Who can join

18 and older, any sex, with Osteoarthritis of Multiple Joints of Ankle or Foot or Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the effect of different analgesic treatments (Tramadol, Paracetamol, Diclofenac) on sympathetic nerve activity, blood pressure, heart rate, heart rate, and vascular function in osteoarthritis patients and healthy subjects.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Pharmaceutical therapeutics for articular regeneration and restoration: state-of-the-art technology for screening small molecular drugs.
    Chen Y, Sun H, Yao X, Yu Y, et al · · 2021 · cited 9× · PMID 34783870 · DOI 10.1007/s00018-021-03983-8

Verify or expand the search:

Other trials of Tramadol

Trials testing the same drug.

Other University of Zurich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03781544.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing